Navigation Links
Ventana Supports World Patient Safety Day, July 25
Date:7/17/2012

TUCSON, Ariz., July 17, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, will join thousands of patients, families, providers, and consumer groups worldwide in observing World Patient Safety Day on July 25 in tribute to those who work to improve the safety and quality of healthcare, and in memory of patients and families who have suffered from medical error.

(Photo: http://photos.prnewswire.com/prnh/20120717/LA41202)

A Southern Arizona-based supplier of automated diagnostic instrumentation and advanced tests, Ventana was established 25 years ago to improve the lives of all patients afflicted with cancer through scientific excellence and a relentless focus on innovation.

Watch the video: Ventana's Patient Safety Initiative.

"The spirit of this global initiative – to offer hope, healing and advocacy for safe healthcare, to save lives and to reduce healthcare costs through the elimination of preventable medical errors– is embodied in our Ventana mission to improve the lives of all patients afflicted with cancer," says Mara G. Aspinall, President, Ventana Medical Systems, Inc.

"As a global leader in helping hospitals, cancer centers, and laboratories worldwide improve patient care, Ventana salutes the organizers of World Patient Safety Day and supports their efforts to increase awareness of the vital importance of timely, accurate diagnosis and optimal treatment for every patient."

The Ventana portfolio of instruments and reagents not only provides accurate and speedy delivery of diagnostic results but also minimizes the risk of patient misidentification caused by mislabeling or tissue cross contamination.

About Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's intuitive, integrated staining, workflow management platforms, and digital pathology solutions optimize laboratory efficiencies to reduce errors, support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving Personalized Healthcare through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.

CONTACT: Jacqueline Bucher, Senior Director, Corporate Communications, +1-520-877-7288, jacquie.bucher@ventana.roche.com

 


'/>"/>
SOURCE Ventana Medical Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
2. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
3. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
4. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
5. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
6. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
7. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
8. Misonix Exhibits at Major Worldwide Spine Conference
9. Sony Announces Worlds First Medical-Grade Monitor Utilizing Breakthrough OLED Technology
10. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
11. World Wound Care Markets (Skin Ulcer, Burns, Surgical/Trauma)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a privately-held ... and developing novel compounds to treat Parkinson,s disease (PD), has ... is a Phase 1/2a randomized, controlled, multicenter study involving patients ... will enroll 50 patients over a 9-to-12-month period. The first ... 10 patients with PD. Participating sites include Denver ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) ... second quarter ended April 1, 2017 .   GAAP ... compared to the prior year period as the sale ... gain, while non-GAAP diluted EPS of $0.50 increased 6.4%.  ... constant currency terms.  Excluding the effects of blood screening ...
(Date:5/10/2017)... 10, 2017 Radiology has become the number ... have also spiraled to the number one ranking as ... than ever before as the most complete and reliable ... with lower back pain an MRI may confirm a ... pain, resulting in entirely different treatment protocols.  In these ...
Breaking Medicine Technology:
(Date:5/22/2017)... ... 22, 2017 , ... Patients who avoid necessary dental and endodontic treatments because ... Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of endodontists offer three ... more sedation methods may be recommended based on the severity of the anxiety experienced ...
(Date:5/22/2017)... ... 2017 , ... “Homeostasis: The Journey of a Manic-Depressive” tells the story in ... Rodriguez takes readers on a rollercoaster ride that includes a midnight trek to the ... a dark place where Donald considers suicide. Readers learn how Donald finally achieves ...
(Date:5/22/2017)... ... May 22, 2017 , ... OSF Ventures, ... investing in InsightRX, an early stage company in San Francisco that has developed ... Greatpoint Ventures Innovation Fund acted as the lead investor in the ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... ... styled corporate text designs created specifically for use in Final Cut Pro X. ... for all media productions. Pixel Film Studios’ ProParagraph Corporate will deliver a professional ...
(Date:5/21/2017)... ... , ... For more than 20 years United Cutlery has been distinguished by ... from functional to fantasy. United Cutlery has always been “Stronger. Sharper” than the competition ... , Offering a range of weapons and tools built for battle, the M48 line ...
Breaking Medicine News(10 mins):